BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 27381607)

  • 1. Dietary Protective Effects Against Hepatocellular Carcinoma Development in Mdr2-/- Knockout Mice.
    Gentileschi MP; Lattanzio C; Menicagli F; Vincenzi B; Cigliana G; Baldi A; Blandino G; Muti P; Fanciulli M; Spugnini EP
    In Vivo; 2016; 30(4):445-50. PubMed ID: 27381607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesis.
    Potikha T; Stoyanov E; Pappo O; Frolov A; Mizrahi L; Olam D; Shnitzer-Perlman T; Weiss I; Barashi N; Peled A; Sass G; Tiegs G; Poirier F; Rabinovich GA; Galun E; Goldenberg D
    Hepatology; 2013 Jul; 58(1):192-204. PubMed ID: 23423643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of the chemopreventive effect on hepatocellular carcinoma development in Mdr2 knockout mice.
    Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Barash H; Domany E; Galun E; Goldenberg D
    Mol Cancer Ther; 2007 Apr; 6(4):1283-91. PubMed ID: 17431106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice.
    Barashi N; Weiss ID; Wald O; Wald H; Beider K; Abraham M; Klein S; Goldenberg D; Axelrod J; Pikarsky E; Abramovitch R; Zeira E; Galun E; Peled A
    Hepatology; 2013 Sep; 58(3):1021-30. PubMed ID: 23526353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 11C-acetate and 18F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma.
    Territo PR; Maluccio M; Riley AA; McCarthy BP; Fletcher J; Tann M; Saxena R; Skill NJ
    BMC Med Imaging; 2015 May; 15():15. PubMed ID: 25981587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model.
    Zahavi T; Lanton T; Divon MS; Salmon A; Peretz T; Galun E; Axelrod JH; Sonnenblick A
    Oncotarget; 2016 Jan; 7(4):4860-70. PubMed ID: 26695439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p21 promotes sustained liver regeneration and hepatocarcinogenesis in chronic cholestatic liver injury.
    Marhenke S; Buitrago-Molina LE; Endig J; Orlik J; Schweitzer N; Klett S; Longerich T; Geffers R; Sánchez Muñoz A; Dorrell C; Katz SF; Lechel A; Weng H; Krech T; Lehmann U; Dooley S; Rudolph KL; Manns MP; Vogel A
    Gut; 2014 Sep; 63(9):1501-12. PubMed ID: 24092862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic liver inflammation modifies DNA methylation at the precancerous stage of murine hepatocarcinogenesis.
    Stoyanov E; Ludwig G; Mizrahi L; Olam D; Schnitzer-Perlman T; Tasika E; Sass G; Tiegs G; Jiang Y; Nie T; Kohler J; Schinazi RF; Vertino PM; Cedar H; Galun E; Goldenberg D
    Oncotarget; 2015 May; 6(13):11047-60. PubMed ID: 25918251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice.
    Katzenellenbogen M; Pappo O; Barash H; Klopstock N; Mizrahi L; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Mitchell LA; Kohen R; Domany E; Galun E; Goldenberg D
    Cancer Res; 2006 Apr; 66(8):4001-10. PubMed ID: 16618719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
    Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Domany E; Galun E; Goldenberg D
    Mol Cancer Res; 2007 Nov; 5(11):1159-70. PubMed ID: 18025261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of galectin-1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma model.
    Potikha T; Pappo O; Mizrahi L; Olam D; Maller SM; Rabinovich GA; Galun E; Goldenberg DS
    FASEB J; 2019 Jul; 33(7):7995-8007. PubMed ID: 30897344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidic acid aberrancies and hepatocellular carcinoma: studies in the MDR2 gene knockout mouse.
    Skill N; Wu J; Xu Y; Zhao Z; Maluccio M
    Cancer Invest; 2013 Feb; 31(2):145-55. PubMed ID: 23362952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of moderate caloric restriction and/or weight cycling on mammary tumor incidence and latency in MMTV-Neu female mice.
    Pape-Ansorge KA; Grande JP; Christensen TA; Maihle NJ; Cleary MP
    Nutr Cancer; 2002; 44(2):162-8. PubMed ID: 12734063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Dietary Restriction on Toxicology and Carcinogenesis Studies in F344/N Rats and B6C3F1 Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 Sep; 460():1-414. PubMed ID: 12587016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum insulin-like growth factor-I and mammary tumor development in ad libitum-fed, chronic calorie-restricted, and intermittent calorie-restricted MMTV-TGF-alpha mice.
    Rogozina OP; Bonorden MJ; Grande JP; Cleary MP
    Cancer Prev Res (Phila); 2009 Aug; 2(8):712-9. PubMed ID: 19654106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenesis: An "Off-Target" Effect of Radiofrequency Ablation.
    Rozenblum N; Zeira E; Scaiewicz V; Bulvik B; Gourevitch S; Yotvat H; Galun E; Goldberg SN
    Radiology; 2015 Aug; 276(2):426-32. PubMed ID: 26203709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice.
    Yoshida S; Ikenaga N; Liu SB; Peng ZW; Chung J; Sverdlov DY; Miyamoto M; Kim YO; Ogawa S; Arch RH; Schuppan D; Popov Y
    Gastroenterology; 2014 Dec; 147(6):1378-92. PubMed ID: 25173753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific genomic and transcriptomic aberrations in tumors induced by partial hepatectomy of a chronically inflamed murine liver.
    Ella E; Heim D; Stoyanov E; Harari-Steinfeld R; Steinfeld I; Pappo O; Perlman TS; Nachmansson N; Rivkin L; Olam D; Abramovitch R; Wege H; Galun E; Goldenberg D
    Oncotarget; 2014 Nov; 5(21):10318-31. PubMed ID: 25401338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV tumor promoting effect is dependent on host genetic background.
    Klopstock N; Katzenellenbogen M; Pappo O; Sklair-Levy M; Olam D; Mizrahi L; Potikha T; Galun E; Goldenberg D
    PLoS One; 2009; 4(4):e5025. PubMed ID: 19340302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
    Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
    BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.